S100A6 gliotransmission modulates neuronal proteostasis and energy production in the mouse and human brain

This study reveals that the neuron-specific protein CaCyBp interacts with astrocyte-derived S100A6 to regulate mitochondrial function and ATP production, thereby modulating neuronal proteostasis in both mouse and human brains.

The Gist

The Big Picture: A Cellular "Power Plant" Maintenance Crew

Imagine your brain is a massive, bustling city. In this city, there are two main types of workers: the Neurons (the electricians and data processors who do the thinking and feeling) and the Astrocytes (the support staff, like janitors and utility managers who keep the environment clean and supplied).

For a long time, scientists knew these two groups talked to each other, but they didn't know exactly how or what they were saying. This paper discovers a specific "text message" system between them that controls the brain's energy supply.

The Key Characters

1. S100A6 (The Messenger): This is a protein found only in the Astrocytes (the support staff). Think of it as a delivery truck leaving the support station.
2. CaCyBp (The Receiver): This is a protein found only inside the Neurons (the electricians). Think of it as a specialized docking station on the neuron's power plant.
3. The Mitochondria (The Power Plant): Inside every neuron, there are tiny power plants that generate electricity (ATP) to keep the brain running.

The Story Unfolds

1. The City-Wide Search

The researchers first mapped out where these proteins live in both mice and humans, from the time they are fetuses all the way to adulthood.

• The Finding: They found that CaCyBp is everywhere in the neurons, like a universal tool that every electrician needs. It's present from the very beginning of brain development.
• The Contrast: S100A6 is strictly in the support staff (astrocytes). It's never found in the neurons themselves.

2. The Delivery and The Docking

The study shows that the Astrocytes release S100A6 (the delivery truck) into the space between cells. The Neurons catch it with their CaCyBp (the docking station).

• The Twist: Once the truck docks, it doesn't just sit there. It goes straight to the Mitochondria (the power plant) inside the neuron.

3. The Energy Boost

This is the most exciting part. When the "delivery truck" (S100A6) docks at the "power plant" (Mitochondria), it acts like a turbocharger.

• What happens? It tightens the electrical gradient in the power plant. In simple terms, it makes the battery charge up faster and more efficiently.
• The Result: The neuron produces more energy (ATP). This extra energy is crucial for the neuron to grow, build its connections, and stay healthy.

4. What Happens if the System Breaks?

The researchers tested what happens if they remove the "docking station" (CaCyBp) or block the "delivery truck" (S100A6).

• The Consequence: Without this signal, the power plant gets sluggish. The neuron can't manage its internal "trash" (protein turnover) as well, and it struggles to generate energy.
• The Analogy: Imagine a city where the power plant stops getting its fuel delivery. The lights flicker, the traffic lights stop working, and the whole city starts to slow down.

Why Does This Matter?

This discovery is like finding a missing link in a chain reaction that keeps our brains alive.

• Brain Development: It explains how the brain grows in the womb. The support staff (astrocytes) are literally feeding the growing neurons energy to help them build their complex networks.
• Aging and Disease: The paper suggests that if this communication breaks down as we get older, or if it goes wrong in diseases like Alzheimer's or Parkinson's, the neurons might start to "run out of gas." This could lead to the brain cells dying or malfunctioning.
• The "Gliotransmitter" Concept: The authors argue that S100A6 is a true "gliotransmitter." Just as neurons talk to each other using chemicals (neurotransmitters), astrocytes talk to neurons using this specific protein to control their energy levels.

The Takeaway

Think of your brain as a high-tech city. This paper reveals that the janitors (astrocytes) have a secret way of handing a "super-charger" (S100A6) to the electricians (neurons). This charger plugs directly into the electrician's power plant, ensuring they have enough juice to keep the city's lights on, the traffic flowing, and the buildings standing tall. If this hand-off fails, the whole system risks a blackout.

Technical Summary

1. Problem Statement

While the protein CaCyBp (Calcyclin binding protein, also known as SIP or Siah-1 interacting protein) is known to regulate cell proliferation, differentiation, and survival through interactions with Siah-1 and Skp1, its physiological role in the developing and adult central nervous system (CNS) remains poorly understood. Specifically:

• The spatiotemporal distribution of CaCyBp across different organ systems and brain regions in both mouse and human models was unknown.
• The cellular identity of CaCyBp-expressing cells (neurons vs. glia) and its specific subcellular localization were not fully characterized.
• The molecular mechanism by which the astrocyte-derived ligand S100A6 (calcyclin) interacts with neuronal CaCyBp to influence neuronal maturation and bioenergetics had not been elucidated.

2. Methodology

The authors employed a multi-modal approach combining comparative neuroanatomy, molecular biology, and cell physiology across mouse and human tissues:

• Tissue Models:
  • Mouse: Embryonic (E18.5), postnatal (P6, P120), and adult tissues.
  • Human: Fetal brains (Gestational Weeks 27–34) and adult brains (57–63 years).
• Anatomical Mapping:
  • Immunohistochemistry (IHC) & Immunofluorescence: Used to map CaCyBp and S100A6 protein distribution.
  • Fluorescent In Situ Hybridization (FISH): Used to localize Cacybp and S100a6 mRNA.
  • Reporter Mice: Utilized CCKBAC/DsRed::GAD67gfp/+ mice to distinguish between glutamatergic (DsRed+) and GABAergic (GFP+) neurons, including CCK+ subsets.
  • Cell-Type Specific Markers: Co-staining with NeuN (neurons), GFAP (astrocytes), IBA1 (microglia), MBP (oligodendrocytes), and various neurotransmitter markers (TH, ChAT, etc.).
• Ultrastructural Analysis:
  • Immunoelectron Microscopy: To determine subcellular localization (specifically mitochondrial association).
  • Structured Illumination Microscopy (SIM): High-resolution imaging of cultured neurons to visualize CaCyBp overlap with OXPHOS complexes.
• Biochemical & Functional Assays:
  • Subcellular Fractionation: Isolation of mitochondrial vs. cytosolic fractions from hippocampal tissue.
  • Western Blotting: Quantification of CaCyBp, OXPHOS complex proteins, and mitochondrial markers (TOM20).
  • Loss-of-Function: shRNA-mediated knockdown of Cacybp in primary neuronal cultures.
  • Gain-of-Function: Treatment of primary neurons with recombinant S100A6 (20 ng/ml) for 6 and 24 hours.
  • Mitochondrial Membrane Potential (MMP) Assay: Used the Mito-ID kit to measure $\Delta\Psi_m$ (electrochemical gradient) in response to S100A6.
  • qPCR: Validation of gene expression levels.

3. Key Contributions

• Comprehensive Atlas: Established the first cell-resolved map of CaCyBp expression in both developing and adult mouse and human brains, confirming evolutionary conservation.
• Cellular Specificity: Demonstrated that CaCyBp is exclusively neuronal (absent in astrocytes, microglia, and oligodendrocytes), while its ligand S100A6 is exclusively glial (astrocytes and ependymoglia).
• Mechanistic Insight: Identified the mitochondria as the primary site of CaCyBp action and revealed a novel astrocyte-to-neuron signaling pathway (gliotransmission) where S100A6 regulates neuronal bioenergetics.
• Functional Link: Linked S100A6-CaCyBp signaling directly to the regulation of the mitochondrial electrochemical gradient and ATP production.

4. Key Results

A. Spatiotemporal Distribution

• Ubiquity: CaCyBp mRNA and protein are found in all major organ systems, with highest expression in the brain, eye, and reproductive tract.
• Brain Localization:
  • Fetal/Embryonic: CaCyBp is present in proliferative radial glia and migrating neuroblasts (E18.5) and persists in postmitotic neurons.
  • Adult: CaCyBp is expressed in diverse neuronal subtypes across the cortex (layers IV-VI), hippocampus (CA1-3, dentate gyrus), striatum, thalamus, hypothalamus, and substantia nigra.
  • Human vs. Mouse: Distribution patterns are highly conserved, though some differences exist (e.g., persistent CaCyBp in the adult human granule cell layer vs. transient expression in mice).
• Ligand Specificity: S100A6 is strictly localized to astrocytes and ependymal cells, supporting a model of intercellular signaling where astrocytes release S100A6 to act on neuronal CaCyBp.

B. Subcellular Localization

• Mitochondrial Targeting: Immunoelectron microscopy and SIM confirmed that a significant portion of CaCyBp localizes to mitochondrial membranes in neurons, specifically co-localizing with OXPHOS complexes (I-V).

C. Functional Mechanism (S100A6-CaCyBp Axis)

• Proteostasis: Knockdown of CaCyBp led to slowed protein turnover and a disproportionate accumulation of OXPHOS proteins, suggesting CaCyBp normally regulates mitochondrial protein degradation/turnover.
• S100A6 Dynamics:
  • S100A6 is not detected in neuronal mitochondria under basal conditions.
  • Upon exposure to recombinant S100A6, the protein accumulates in neuronal mitochondria within 6 hours.
  • This exposure causes a transient decrease in mitochondrial CaCyBp levels at 6 hours, followed by a recovery at 24 hours.
• Bioenergetic Impact:
  • The 6-hour reduction in mitochondrial CaCyBp (mimicking S100A6 stimulation) leads to an increase in mitochondrial load of OXPHOS components and TOM20.
  • Crucially, S100A6 exposure significantly increases the Mitochondrial Membrane Potential (MMP) at 6 hours, indicating enhanced electrochemical gradients and improved ATP production capacity.
  • This effect is transient, normalizing by 24 hours.

5. Significance

• Novel Gliotransmission Mechanism: The study defines S100A6 as a true gliotransmitter that signals from astrocytes to neurons to modulate mitochondrial function, a critical component of neuronal health and plasticity.
• Metabolic Regulation: It reveals that neuronal proteostasis and energy production are not autonomous but are actively tuned by glial-derived signals via the S100A6-CaCyBp axis.
• Clinical Relevance: Given the role of CaCyBp in mitochondrial stability and its dysregulation in neurodegenerative diseases (Alzheimer's, Parkinson's, Huntington's, ALS) and psychiatric disorders (Bipolar disorder), this pathway offers a potential therapeutic target. The findings suggest that disruptions in this signaling axis could contribute to the mitochondrial failure and cytoskeletal instability observed in these pathologies.
• Developmental Role: The presence of CaCyBp in neurogenic niches suggests it is essential for tuning bioenergetics during neuronal migration and maturation.

In summary, the paper establishes that S100A6 released by astrocytes acts as a gliotransmitter to modulate neuronal CaCyBp, which in turn regulates mitochondrial membrane potential and ATP production, thereby linking glial activity to neuronal metabolic health and proteostasis.